Staar Surgical Co. said it plans to terminate its proposed $1.6 billion sale to Alcon Inc. based on preliminary results from today’s shareholder vote. As a result, Staar will remain a standalone, ...
14don MSN
Dekaney HS leaders introduce more testing, changes to student data tracking to avoid state takeover
Spring ISD administrators have been rolling out an aggressive turnaround plan after Dekaney High School received four consecutive years of failing ratings.
8don MSN
HISD to pilot ‘Future 2' K-8 schools focused on AI, design thinking and accelerated learning
HISD's state-appointed Superintendent Mike Miles also revisited the potential of school consolidations, which he said could save the district about $1 million to $1.5 million each.
The Beaumont Enterprise on MSN
Beaumont ISD takeover: TEA's community meeting gives answers, leaves questions
At a community meeting, TEA detailed its Beaumont ISD takeover and urged more Board of Managers applicants by mid-February.
Jan 6 (Reuters) - STAAR Surgical (STAA.O), opens new tab said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon (ALCC.S), opens new tab after failing to secure ...
SCUCISD trustees on Jan. 22 reviewed the Texas Academic Performance Report, or TAPR, which is required to be shared with district stakeholders annually.
Jan 15 (Reuters) - Staar Surgical (STAA.O), opens new tab said on Thursday its CEO Stephen Farrell will step down by the end of the month as part of the medtech company's settlement deal with ...
A STAAR Surgical (STAA) holder vote on Alcon's (ALC) planned purchase may be delayed as the companies are contractually obligated to delay while Alcon considers raising its offer again, according to a ...
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the ...
Staar Surgical and Broadwood Partners entered into a cooperation agreement that places Neal C. Bradsher and Richard T. LeBuhn of Broadwood and Christopher Wang of Yunqi Capital on Staar's board of ...
Shareholders of Staar Surgical rejected a proposal to sell the company to Alcon for about $1.6 billion, a win for activist investors who had campaigned to block the deal Staar, a maker of implantable ...
Why the Price Target for Pacific Biosciences of California Matters Now Pacific Biosciences of California is back in focus as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results